From: [18F]FDG-PET/CT-based risk stratification in women with locally advanced uterine cervical cancer
 | Studied cohort (n = 183) | Kidd cohort (n = 234) | |||||
---|---|---|---|---|---|---|---|
Metabolic tumor volume (cm3) Median [range] | 47.04 [3.01-351.88] | Â | 47.07* [3.01-351.88] | ||||
Tumor SUVmaxMedian [range] | 15.57 [3.7-60.69] |  | 12.4* [2.1–50.4] | ||||
Highest [18F]FDG-positive lymph node | Â | Â | Â | Â | |||
No suspicious nodes | Â | 75 (40.9%) | Â | 109 (46.6%) | |||
Pelvic | Â | Â | Â | 68 (37.2%) | Â | 84 (35.9%) | |
Para-aortic | Â | Â | 32 (17.5%) | Â | 31 (13.2%) | ||
Supraclaviculair | Â | Â | 8 (4.4%) | Â | Â | 10 (4.3%) | |
Treatment | Â | Â | Â | Â | Â | Â | |
Chemoradiation | Â | Â | 137 (74.9%) | Â | 90% | ||
Radiation with hyperthermia | Â | 33 (18.0%) | Â | none | |||
Radiation therapy only | Â | 9 (4.9%) | Â | Â | 10% | ||
Palliatieve chemotherapy and radiotherapy | 4 (2.2%) | Â | Â | none |